Among patients receiving radiation therapy (RT) for prostate cancer, intensity-modulated radiation therapy is significantly associated with a reduced risk for second primary solid malignancies compared with 3D conformal RT.
However, a history of cancer more than one year before COVID-19 diagnosis not tied to increased mortality or hospitalization
Updated guideline discusses advanced radiation therapy techniques and places emphasis on multidisciplinary care
Although most men with low-risk prostate cancer are now managed initially with active surveillance, use of this approach remains suboptimal, according to investigators.
Further studies are needed to evaluate oncologic outcomes after postoperative radiation therapy.
Study reveals factors that could distinguish PSA bounce from biochemical recurrence after stereotactic body radiation therapy for prostate cancer.
Disparities greatest most recently and for cancers for which PBT is the recommended radiation therapy modality
An overview of prostate cancer metastases to bone is presented, including strategies for pain assessment and palliative radiotherapy.
Investigators said “it is important to weigh the potential short- and long-term toxicity of pelvic RT against the possible but modest absolute reduction in [all-cause mortality] when considering its use in men with a single or a few positive LNs.”
Investigators compared the mental health status of men undergoing surgery, radiation therapy, and active surveillance for localized prostate cancer.
